AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
May 11, 2020
29821_dirs_2020-05-11_e1395493-7ca3-432a-8755-87c74f622216.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-05-07
Reporting Person: FUJIMORI YOSHIAKI (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-07 | Deferred Stock Units | $ | A | 5000.0000 | Acquired | Common Stock (5000.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Reflects a value of $185,000 divided by the closing price of common stock on the date of grant.
F3: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.